EP1804840A1 - Preparation cosmetique anti-transpirante - Google Patents
Preparation cosmetique anti-transpiranteInfo
- Publication number
- EP1804840A1 EP1804840A1 EP05801499A EP05801499A EP1804840A1 EP 1804840 A1 EP1804840 A1 EP 1804840A1 EP 05801499 A EP05801499 A EP 05801499A EP 05801499 A EP05801499 A EP 05801499A EP 1804840 A1 EP1804840 A1 EP 1804840A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sulfonamide
- nkcc1
- modulators
- inhibitors
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Definitions
- the invention relates to deodorant or antiperspirant formulations with a new mode of action.
- the invention further comprises cosmetic preparations which have the pleasant accompanying effect of reducing perspiration.
- antiperspirants and deodorants (deodorants) are available in a variety of product forms, with scooters, pump sprayers and aerosols dominating in Europe, and pens in the US, Central and South America. Both anhydrous (suspensions) and water-containing products (hydro-alcoholic formulations, emulsions) are known.
- the pens are mainly divided into two types of formulation.
- Deodorant sticks contain primarily soap, such as sodium stearate, oil body and
- Bactericides They have an alkaline pH of greater than 9. The consumer regards the soapy skin feeling associated with these pins as disadvantageous.
- Aluminum chlorohydrate (ACH). These formulations are anhydrous and require special thickener systems, for. B. based on mixtures of
- Anhydrous solid or semi-solid formulations are characterized in that one or more solid particulate antiperspirant agents are suspended in a carrier.
- the carrier is at least one or more volatile oils, one or more non-volatile emollients and one or more thickeners.
- Anhydrous solid and semi-solid products are characterized by a high effectiveness and a powdery, non-sticky, velvety-silky skin feeling.
- a disadvantage is the tendency to form white residues. This can be prevented by selecting and concentrating the raw materials, in particular the oils and thickeners.
- Antiperspirant formulations with high levels of clays (US 4526780, US 5019375) or silicas (US 4937069, US 5069897, DE 69005029) with a content preferably greater than 2%. Disadvantage is the unwanted Weissein, the
- silicone elastomers crosslinked silicone polymers
- silicone latex copolymers WO 98042366
- thickener combinations based on triglycerides such as, for example, Tribehenin (US 5718890, WO 9717941, WO 0187251), also together with inorganic
- the classical antiperspirant active ingredients such as aluminum salts or aluminum / zirconium salts inhibit the flow of sweat by obstructing the ducts of the sweat glands. Therefore, there may be a congestion of sweat within the gland.
- aluminum salts as aluminum hydroxychlorides can cause skin damage if used frequently and on sensitive persons.
- the use of the aluminum salts can cause discoloration of textiles which come into contact with the antiperspirant.
- signaling from the nerve to the sweat gland cell is not mediated via catecholamines, as usual, but through the neurotransmitter acetylcholine (ACh) (Sato et al., 1989).
- ACh neurotransmitter acetylcholine
- the depolarization of the synaptic membrane triggered by the corresponding action potential leads to the opening of potential-dependent calcium channels.
- the subsequent extracellular calcium influx triggers the exocytosis of the acetylcholine-containing synaptic vesicles.
- the neurotransmitters released into the synaptic cleft bind to the G protein-coupled muscarinic acetylcholine receptor of the sweat gland cell (Fig. 1).
- the signal is transferred via the G proteins to the PLC ß , further leads to an activation of protein kinase C and to the release of intracellular calcium from the endoplasmic calcium stores (Figure 2) (Quinton et al.).
- Figure 2 Quinton et al.
- an ion gradient occurs in which essentially the sodium / potassium ATPase, sodium and chloride channels and the sodium-potassium chloride cotransporter (NKCC1) are involved (FIG. 3).
- the resulting osmotic gradient leads to an influx of water from the basolateral to the apical (luminal) side of the cell.
- a cosmetic preparation containing deodorants and / or antiperspirant active ingredients and modulators and / or inhibitors of NKCC1 remedies the disadvantages of the prior art.
- Such preparations are particularly skin-care and cosmetically appealing. They lead to less discoloration of garments.
- Modulators / inhibitors of NKCC1 are highly effective even at low concentrations.
- modulators and / or inhibitors of NKCC1 at least one of the compounds equol (4 ', 7-dihydroxyisoflavan), genistein (5,7,4 ' - trihydroxy-isoflavone), brocrinate, bumetanide, furosemide, soybean extract, torasemide , 2- (N- Benzyl) -amino-4-chlorobenzoic acid-5-sulfonamide, 4-chlorobenzoic acid-3-sulfonamide, 2-hydroxy-4-chlorobenzoic acid-5-sulfonamide, 4-chlorobenzoic acid-3- (N-piperidyl) -sulfonamide, 2-methoxybenzoic acid 5-sulfonamide, benzoic acid 4-sulfonamide, N, N-di-n-propylbenzoic acid 4-sulfonamide, 2-methoxy-5-sulfonamidobenzoic acid methyl ester, nico
- NKCC1 As modulators and / or inhibitors of NKCC1, at least one of the compounds equol, geniistein, brocrinate, bumetanide, furosemide, soybean extract, torasemide, 2-methoxybenzoic acid-5-sulfonamide, benzoic acid-4-sulfonamide, N, N- Di-n-propylbenzoic acid 4-sulfonamide, 2-methoxy-5-sulfonamidobenzoic acid methyl ester is selected. It is particularly preferred if at least one of the compounds equol, geniistein, brocrinate, soybean extract is selected as modulators and / or inhibitors of NKCC1.
- the concentration of modulators and / or inhibitors of NKCC1 0.1 to 3 wt.%, Particularly preferably 0.3 to 1, 5 wt.%, Particularly preferably 0.5 to 1, 1 wt.% , very particularly preferably 0.6 to 0.9 wt.%, Based on the total weight of the preparation, or even 0.00001 to 0.01 mol / l, particularly preferably 0.0001 to 0.001 mol / l.
- the preparation contains genistein and a substance selected from the group of ethyl methyl ketone, acetone, butylene glycol, methyl propane diol. Furthermore, it is preferred if the preparation contains equol and a substance selected from the group propylene carbonate, PEG-40 hydrogenated castor oil.
- modulators and / or inhibitors NKCC1 for influencing the cellular ion transport remedies the disadvantages of the prior art. It is particularly preferred when bumetanide or furosemide is used to influence the cellular lonentransportes. Furthermore, it is particularly preferred if soy extract is used to inhibit perspiration of sweat glands, in particular human sweat glands.
- the invention also encompasses the use of modulators and / or inhibitors NKCC1 for inhibiting the sweat formation of sweat glands, in particular human sweat glands.
- NKCC2 Na-K-Cl cotransporter
- the inhibitors or modulators of the Na-K-Cl cotransporter 1, such as, for example, bumetanide and furosemide, are suitable for cosmetic use as antiperspirants.
- bumetanide inhibits sweat secretion. Bumetanide affects NaCl secretion in the secretory glands. Structures that affect NKCC1 can be used to treat excessive perspiration on the palms (hyperhidrosis).
- NKCC1 Immunohistochemical analysis revealed strong NKCC1 labeling of the basal lateral plasma membrane areas of the rat gland and human sweat glands, but no labeling of the apical plasma membrane area. Compared to the secretory glands, the labeling was significantly reduced in the Reabsorptionsgang. Anti-NKCC1 antibodies did not label the epidermis. An identical labeling pattern was found in the sweat glands of the mouse. Anti-NKCC2 antibodies did not label sweat glands, but control kidney cuts. We localized the NKCC1 locally to the basal-lateral plasma membrane of the secrets of sweat glands. This suggests that an NKCC protein is involved in sweat formation as well as healing of shrinkage observed in eccrine clear cells after sweat introduction.
- antiperspirant active agents to be used according to the invention should not be restrictive in any way:
- Aluminum salts such as aluminum chloride AICI 3 , aluminum sulfate Al 2 (SCu) 3
- Aluminum chlorides of the empirical empirical formula [Al 2 (OH) n Cl n ], where m + n 6 - aluminum chlorohydrate [Al 2 (OH) 5 Cl] x H 2 O
- Al complexes Reach 501 (Reheis), AACH-324 (Summit), Aloxicoll P (Giulini), Aloxicoll SD100 - Aluminum sesquichlorohydrate [Al 2 (OH) 4 , 5 Cli, 5 ] x H 2 O
- Standard AI complexes Aluminum sesquichlorohydrate (Reheis), ACH-308 (Summit), Aloxicoll 31 L (Giulini)
- Standard Al / Zr Complexes Rezal 33GP (Reheis), AZG-7164 (Summit), Zirconal P3G (Giulini) Activated Al / Zr Complexes: Reach AZZ 902 (Reheis), AAZG-7160 (Summit), Zircon
- Al / Zr Complexes Reach AZP 855 (Reheis), AAZG-7167 (Summit), Zirconal AP4G (Giulini) - Aluminum / Zirconium Pentachlorohydrex Glycine [Al 8 Zr (OH) 23 Cl 5 ] x H 2 O x Gly Standard Al / Zr Complexes: Rezal 67 (Reheis), Zirconal L540 (Giulini) Activated Al / Zr Complexes: Reach AZN 885 (Reheis) - Aluminum / Zirconium Octachlorohydrex Glycine [Al 8 Zr (OH) 20 Cl 8 ] x H 2 O x GIy
- antiperspirant effecters are used in the anhydrous stick formulations according to the invention in powder form in an amount of from 5 to 35% by weight, preferably from 10 to 25% by weight.
- antiperspirant effect with a fine degree of grinding, d. H. with a mean particle diameter of 50 microns maximum.
- the diameter should be ⁇ 50 microns, most preferred are Vermahlungsgrade at which 95% of the particles are smaller than 10 microns.
- Advantageous may also be the use of AT salt suspensions or gels in which powdered aluminum and aluminum / zirconium salts are dispersed in various oils.
- Deodorants can be added to the preparations according to the invention.
- the usual cosmetic deodorants are based on different active principles.
- antimicrobial substances in cosmetic deodorants, the bacterial flora on the skin can be reduced.
- only the odor causing microorganisms should be effectively reduced.
- the sweat flow itself is not affected, in the ideal case, only the microbial decomposition of the sweat is temporarily stopped.
- the combination of astringents with antimicrobial active substances in one and the same composition is also common.
- odor maskers such as the common perfume ingredients, odor absorbers, for example, the phyllosilicates described in DE 40 09 347, of these in particular montmorillonite, kaolinite, INt, beidellite, nontronite, saponite, hectorite, bentonite, smectite, furthermore, for example, zinc salts of ricinoleic acid.
- Germ-inhibiting agents are also suitable for incorporation into the emulsions of the invention.
- Advantageous substances are, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether (Irgasan), 1,6-di- (4-chlorophenylbiguanido) -hexane (chlorhexidine), 3,4,4'-trichlorocarbanilide, quaternary ammonium compounds, clove oil, mint oil, thyme oil, triethyl citrate, farnesol (3,7,11-trimethyl-2,6,10-dodecatriene-1-ol) and those described in DE 37 40 186, DE 39 38 140, DE 42 04 321, DE 42 29 707, DE 42 29 737, DE 42 37 081, DE 43 09 372, DE 43 24 219 described effective agents. Also, sodium bicarbonate is advantageous to use.
- the list of active substances or combinations of active substances which can be used in the emulsions according to the invention should of course not be limiting.
- the amount of deodorants (one or more compounds) in the preparations is preferably 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-% based on the total weight of the preparation.
- Formulation example 16 O / W emulsions
- Example Formulation 17 Microemulsions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004052707A DE102004052707A1 (de) | 2004-10-22 | 2004-10-22 | Schweiß verringernde kosmetische Zubereitung |
PCT/EP2005/055448 WO2006042863A1 (fr) | 2004-10-22 | 2005-10-21 | Preparation cosmetique anti-transpirante |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1804840A1 true EP1804840A1 (fr) | 2007-07-11 |
Family
ID=35502618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05801499A Ceased EP1804840A1 (fr) | 2004-10-22 | 2005-10-21 | Preparation cosmetique anti-transpirante |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1804840A1 (fr) |
JP (1) | JP2008517039A (fr) |
DE (1) | DE102004052707A1 (fr) |
WO (1) | WO2006042863A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022258385A2 (fr) | 2021-06-07 | 2022-12-15 | Unilever Ip Holdings B.V. | Compositions et méthodes de régulation de la production de sueur |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019375A (en) * | 1989-03-14 | 1991-05-28 | The Procter & Gamble Company | Low residue antiperspirant creams |
US6309657B2 (en) * | 1999-02-12 | 2001-10-30 | The Procter & Gamble Company | Cosmetic compositions |
JP3661981B2 (ja) * | 1999-06-09 | 2005-06-22 | 株式会社ノエビア | 制汗剤 |
JP4033605B2 (ja) * | 2000-06-19 | 2008-01-16 | ライオン株式会社 | エアゾール型制汗剤組成物 |
WO2003087840A2 (fr) * | 2002-04-11 | 2003-10-23 | Oxford Glycosciences (Uk) Ltd | Proteine intervenant dans le cancer |
DE10260954A1 (de) * | 2002-12-20 | 2004-07-01 | Henkel Kgaa | Arylsulfatase-Inhibitoren in Deodorantien und Antitranspirantien |
EP1510200B1 (fr) * | 2003-08-26 | 2006-10-11 | Johnson & Johnson Consumer France SAS | Composition antiperspirante stabilisée comprenant de produits dérivés du soja |
DE102004006829A1 (de) * | 2004-02-09 | 2005-08-25 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Isoflavonen und Antitranspirantwirkstoffen, sowie die Verwendung von Isoflavonen und Antitranspirantwirkstoffen zur Herstellung kosmetischer und dermatologischer Zubereitungen zur Bekämpfung von Sebum |
-
2004
- 2004-10-22 DE DE102004052707A patent/DE102004052707A1/de not_active Withdrawn
-
2005
- 2005-10-21 JP JP2007537284A patent/JP2008517039A/ja active Pending
- 2005-10-21 WO PCT/EP2005/055448 patent/WO2006042863A1/fr active Application Filing
- 2005-10-21 EP EP05801499A patent/EP1804840A1/fr not_active Ceased
Non-Patent Citations (1)
Title |
---|
See references of WO2006042863A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE102004052707A1 (de) | 2006-04-27 |
WO2006042863A1 (fr) | 2006-04-27 |
JP2008517039A (ja) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2313059B1 (fr) | Préparations cosmétiques avec de l argent passivé | |
EP1755531B1 (fr) | Formulation anti-transpiration aqueuse | |
EP2651521A2 (fr) | Compositions anti-transpirantes aqueuses à masquage amélioré des sels résiduels | |
WO2011003673A2 (fr) | Compositions cosmétiques contenant des suspensions de sels d'argent | |
DE102007032642B4 (de) | Verwendung von kurzkettigen Glykolen als antitranspirantwirksame Mittel | |
EP2301516B1 (fr) | Préparations d'aérosol dotées de matières particulaires stabilisées | |
DE102016220085A1 (de) | geruchsreduzierende Körperpflegemittel | |
WO2007071474A1 (fr) | Action longue duree amelioree d'antitranspirants | |
EP2442780B1 (fr) | Compositions cosmétiques contenant du lactate d'argent | |
EP1804840A1 (fr) | Preparation cosmetique anti-transpirante | |
EP2934459B1 (fr) | Protection améliorée contre l'odeur corporelle | |
DE102018213830A1 (de) | "Tetrahydroxypropyl Ethylenediamin oder seine Salze als Wirkstoff zur Reduzierung der Schweißsekretion" | |
DE102012223553A1 (de) | Verwendung von Aluminiumsalzen gegen Stress-Schwitzen | |
EP2442781B1 (fr) | Compositions cosmétiques contenant du sulfate d'argent | |
DE102015223837A1 (de) | Deodorantien mit Metallpartikeln und Salzen der Kohlensäure | |
EP3250294B1 (fr) | Antitranspirant contenant acide salicylique et des derives acides aminopolycarboxyliques | |
DE202006015778U1 (de) | Hautpflegendes Deodorant/Antitranspirant | |
EP1393712A2 (fr) | Compositions antisudorifiques cosmétiques et dermatologiques contenant un épaississant argileux et une polyoléfine | |
DE102019126254A1 (de) | Schlechtgeruchsverringerung durch Mg-Komplex in Deo-Emulsion für Aerosole, Deo, umfassend dieselbe und Verwendung des Deos | |
DE102019133191A1 (de) | Lösliche Oligomere von Propandiol als Wirkstoff zur Regulierung der Schweißsekretion | |
DE102019126253A1 (de) | Antibakterielle Wirkung durch Mg-Komplex in Deo-Emulsion für Aerosole, Deo, umfassend dieselbe und Verwendung des Deos | |
DE102009004270A1 (de) | Aromatische Diole als antitranspirantwirksame Mittel | |
DE102015223846A1 (de) | Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen Alkoholen | |
DE102019126256A1 (de) | Nachhaltige Deo-Emulsion für Roll-on Deo mit antibakterieller Wirkung, Deo, umfassend dieselbe und Verwendung des Deos | |
DE102018213831A1 (de) | "Carnitin oder seine Salze als Wirkstoff zur Reduzierung der Schweißsekretion" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070522 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TERSTEGEN, LARA Inventor name: SCHMIDT-ROSE, THORSTEN |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20100119 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20100318 |